October 5-7 | Arizona Biltmore

Latus Bio

P. Peter Ghoroghchian, CEO

Oct. 5 | 9:30am | FLW Ballroom G

Philadelphia, PA

(Private)

We develop gene therapies designed to target the right cell types in the right tissues, to fundamentally impact genetic diseases like CLN2 and Huntington’s Disease

www.latusbio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions